1 / 8

Metodology for the establishment of regional 2020 targets

Metodology for the establishment of regional 2020 targets. Mónica Alonso González Panamerican health organization PRIMER FORO LATINOAMERICANO Y DEL CARIBE SOBRE EL CONTINUO DE ATENCIÓN DEL VIH Ciudad de México, 26 a 28 de mayo del 2014. Outline of the presentation.

keith
Télécharger la présentation

Metodology for the establishment of regional 2020 targets

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Metodologyforthe establishment of regional 2020 targets Mónica Alonso González Panamericanhealthorganization PRIMER FORO LATINOAMERICANO Y DEL CARIBE SOBRE EL CONTINUO DE ATENCIÓN DEL VIH Ciudad de México, 26 a 28 de mayo del 2014

  2. Outline of the presentation • 1. Why do we need new targets?and why use the framework of the cascade of the continuum of care? • 2. What is the operational definition of each target and the methodology to monitor the targets?

  3. Whythe new targets and why use thecascadeframework? • New evidence and new polocies notyetreflected in new targets. • Ambitious targets supportedbyevidence • Regional targets refer to programaticoutcomes and results. • We are usingthecascadeframeowrkbecause : • Guide to immediateactions to be conductedbyprograms • Reinforcesthe concept of interrelatedactions and outcomes • Adoption/adaptation at country level. • Sum of allcountrieswillpermit La suma de todos los países • reaching regional targets. • Process at global and regional level

  4. Goal 1. Increasing persons with HIV that know their diagnosis • By 2020, 90% of persons with HIV know their status. • 2013 baseline: • Cumulative HIV cases from HIV case base dsurveillance (source: HIV Surveillancesystem), • Substract HIV deaths (adjustforsubregister) (subregisterbasedon IHME orotherstudy; i.e 30%). • Alternatively, countries can use othermethodswithspecialstudies. Note: Diagnosis in HIV exposedchildrenshouldfollow targets establishedbytheeliminationinitiative (all HIV exposedchildrenshouldhave a definitive diagnosis) 90

  5. Goal 2. Decreasing late diagnosis • By 2020, 10% or less of persons have a first CD4 count under 200 cel/mm3. • 2013 Baseline will be the percent of persons with first CD4 < 200 cel/ml in relation to all persons with baseline CD4 that year. • Improvement in availability of data: routine program data. • Alternatively, signs and symptoms indicative of advanced HIV infection at the moment of diagnosis may be used (OI…)

  6. Goal 3. Increasing Persons on antiretroviral treatment • By 2020, 90% of the estimated eligible persons for treatment will be on ART.That should represent 81% of estimated PLWH . • 2013 Baseline: Total number of persons on Art in 2013, come from program data. The denominator comes from Spectrum estimates of persons eligible for treatment. Subtarget: By 2020, 90% of children (0 a 14 y.o) eligible for treatment are receiving ART. 90

  7. Goal 4. Increasing persons on treatment with undetectable viral load. • By 2020, 90% of persons on ART are virally suppressed (viral load <50 copies/ml). It should represent 73% of estimated PLWH. • 2013 baseline: Persons on ART with undetectable VL, from progra/lab registers in relation to all persons on ART with a VL (last VL) in a specific year (2013). • Alternatively: a special study with a representative sample can produce this information. • If using programatic data: The coverage of yearly VL tests needs to be high in order for the value of the indicator to be acceptable to use. An acceptable coverage value is >70% of patients on ART have a VL in the year. 90

  8. Thank you

More Related